Claim/exemption information - Registry number 3642576
List of suggested corrective measures
Disclose an appropriate emergency telephone number.
Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically “skull and crossbones”.
Disclose inhalation, ingestion, skin contact, and eye contact as likely routes of exposure.
Disclose the HMIRA registry number and correct date of decision granting the exemption, and clearly link which ingredients and concentrations are part of the subject of the claim for exemption under the HMIRA.
Disclose the additional hazard classifications for the product (see appendix 1).
Disclose the auto-ignition temperature.
Disclose the common name and synonyms for the ingredients listed in section 3 of the SDS.
Disclose the conditions to avoid.
Disclose the correct and complete LD50 values (see appendix 5).
Disclose the flammability of the product.
Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 2).
Disclose the information on personal precautions, protective equipment and emergency procedures in section 6 of the SDS.
Disclose the most important symptoms and effects, whether acute or delayed in section 4 of the SDS.
Disclose the percent of unknown dermal toxicity.
Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 2).
Disclose the product oral and dermal acute toxicity estimates (ATEs) of 500 mg/kg (0% unknown) and 500 mg/kg (99% unknown), respectively.
Disclose the reactivity of the product.
Disclose the relevant conditions for safe storage (see appendix 4).
Disclose the relevant first-aid measures (see appendix 3).
Disclose the relevant precautions for safe handling (see appendix 4).
Disclose the restrictions on use.